Hyperglycosylated hCG is a form of hCG with more complex oligosaccharide side chains. A specific immunoassay was developed to measure hyperglycosylated hCG. Levels were measured in urine samples from 1157 women between 11 to 22 weeks of gestation, undergoing genetic analysis because of advanced mate
Serum hyperglycosylated hCG: a potential screening test for fetal Down syndrome
โ Scribed by Shohreh Shahabi; Utku A. Oz; Ray O. Bahado-Singh; Maurice J. Mahoney; Aziza Omrani; Alexander Baumgarten; Laurence A. Cole
- Publisher
- John Wiley and Sons
- Year
- 1999
- Tongue
- English
- Weight
- 111 KB
- Volume
- 19
- Category
- Article
- ISSN
- 0197-3851
No coin nor oath required. For personal study only.
โฆ Synopsis
correctly normalize urine data. The tighter distribution of hyperglycosylated hCG measurements in serum may compensate for the lesser elevation of values in Down syndrome cases. Hyperglycosylated hCG determinations might be equally useful in urine and serum samples. 60 per cent sensitivity is suggested with as little as 1.5 per cent false-positive rate. It might be possible to combine serum hyperglycosylated hCG with established serum markers to achieve higher detection rates. Hyperglycosylated hCG measurements could, for instance, replace or supplement regular hCG in the serum triple-screen test. Larger studies are now needed to confirm these preliminary observations.
๐ SIMILAR VOLUMES
Hyperglycosylated hCG (H-hCG) is a minor variant of hCG with abnormal oligosaccharide side chains. It is the principal gonadotropin detected in the serum and urine of patients with gestational choriocarcinoma. A monoclonal antibody was produced against this antigen and an immunoassay developed. Leve
To assess the influence of in vitro fertilization (IVF) on maternal serum human chorionic gonadotrophin (hCG) and alpha-fetoprotein (AFP), the maternal serum hCG and AFP values were studied in 67 IVF pregnancies and compared with the results of a control group of 4732 spontaneously conceiving patien
Published studies have reached varying conclusions as to the benefit of replacing human chorionic gonadotropin (hCG) measurements with the free -subunit of hCG (the free -subunit) for Down syndrome screening. One study reports 14 per cent higher detection for the free -subunit, while another finds a
Variable results have been reported using urine -core fragment as a marker for fetal Down syndrome. Initial studies by Cuckle et al. (1994) and Canick et al. (1995) indicated that -core fragment was an outstanding marker, detecting >80 per cent of Down syndrome cases. Since these reports, widely var